Gynecologic Cancer Program Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Cervix Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Cervix
D0946
Bakitas
Other Female Genital Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Female Genital
D0946
Bakitas
Other Urinary Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Urinary
D0946
Bakitas
Ovary Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Ovary
D0946
Bakitas
Uterus Clinical Trials
A Randomized Phase III Evaluation Of Docetaxel (NSC #628503) And Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865, Ind #113912) Versus Docetaxel (NSC #628503) And Gemcitabine (NSC #613327) Plus G-CSF With Placebo In The Treatment Of Recurrent Or Advanced Leiomyosarcoma Of The Uterus. NCI Supplied Agent: Bevacizumab (NSC #704865, IND #113912)
Uterus
G250
DeMars
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel In Chemotherapy-Naïve Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus or Ovary
Uterus
G261
DeMars
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Uterus
D0946
Bakitas





